Oriola Oyj Stock Price

HLSE:ORIOLA Community·€165.6m Market Cap

1 Narratives written by author
0 Comments on narratives written by author
7 Fair Values set on narratives written by author

Author Program NEW Create Narrative

ORIOLA Share Price Performance

€0.90

-0.17 (-15.98%)

€1.00

Fair Value

€0.90

-0.17 (-15.98%)

10.1% undervalued

€1.00

Fair Value

€0.90

€1.00

Fri, 26 Jun 26

Fair Value€1.00

Share Pricen/a

ORIOLA Community Narratives

AnalystConsensusTarget's

Fair Value

Fair Value €1 10.1% undervalued

Nordic Healthcare Demand And ERP Program Will Drive Stronger Long Term Earnings

Oriola Oyj

Nordic Healthcare Demand And ERP Program Will Drive Stronger Long Term Earnings

Oriola sits at the center of getting medicines and health products to pharmacies and hospitals across the Nordics, and rising healthcare needs could keep volumes growing even as the market worries about near-term noise. A major systems overhaul is meant to cut manual work and costs over time, but delays, cost overruns, or weaker pharmacy demand could keep profits under pressure.Read more

€1

10.1% undervalued

AnalystConsensusTarget's

Fair Value

Profit Margin

8.49%

Future PE

11.37x

Price in 2029

€1.2

Trending Discussion

No trending discussion available.

Snowflake Analysis

Good value with moderate growth potential.

1 Risk

2 Rewards

View Full Analysis

Oriola Oyj Key Details

Last Reported Earnings

Jun 30, 2026

Next Reporting Earnings

Oct 29, 2026

: -0.11
: 8.81%
: -1.02%
: 76.0%

View Full Analysis

About ORIOLA

Founded: 1907
Employees: 796
CEO: Katarina Gabrielson
WebsiteView website: oriola.com

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.